Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 703

1.

Prospective, randomized trial of bioresorbable scaffolds vs. everolimus-eluting stents in patients undergoing coronary stenting for myocardial infarction: the Intracoronary Scaffold Assessment a Randomized evaluation of Absorb in Myocardial Infarction (ISAR-Absorb MI) trial.

Byrne RA, Alfonso F, Schneider S, Maeng M, Wiebe J, Kretov E, Bradaric C, Rai H, Cuesta J, Rivero F, Hoppmann P, Schlichtenmaier J, Christiansen EH, Cassese S, Joner M, Schunkert H, Laugwitz KL, Kastrati A.

Eur Heart J. 2018 Dec 5. doi: 10.1093/eurheartj/ehy710. [Epub ahead of print]

PMID:
30520980
2.

Differential Prognostic Value of Galectin-3 According to Carbohydrate Antigen 125 Levels in Transcatheter Aortic Valve Implantation.

Rheude T, Pellegrini C, Núñez J, Joner M, Trenkwalder T, Mayr NP, Holdenrieder S, Bodi V, Koenig W, Kasel AM, Schunkert H, Kastrati A, Hengstenberg C, Husser O.

Rev Esp Cardiol (Engl Ed). 2018 Oct 25. pii: S1885-5857(18)30390-6. doi: 10.1016/j.rec.2018.09.006. [Epub ahead of print] English, Spanish.

PMID:
30482731
3.

Effects of the coronary artery disease associated LPA and 9p21 loci on risk of aortic valve stenosis.

Trenkwalder T, Nelson CP, Musameh MD, Mordi IR, Kessler T, Pellegrini C, Debiec R, Rheude T, Lazovic V, Zeng L, Martinsson A, Gustav Smith J, Gådin JR, Franco-Cereceda A, Eriksson P, Nielsen JB, Graham SE, Willer CJ, Hveem K, Kastrati A, Braund PS, Palmer CNA, Aracil A, Husser O, Koenig W, Schunkert H, Lang CC, Hengstenberg C, Samani NJ.

Int J Cardiol. 2018 Nov 17. pii: S0167-5273(18)31830-8. doi: 10.1016/j.ijcard.2018.11.094. [Epub ahead of print]

PMID:
30482443
4.

The early repolarization pattern: Echocardiographic characteristics in elite athletes.

Reinhard W, Trenkwalder T, Haller B, Meindl C, Schoenfeld J, Kaess BM, Hengstenberg C, Schunkert H, Pressler A, Halle M, Scherr J.

Ann Noninvasive Electrocardiol. 2018 Nov 14:e12617. doi: 10.1111/anec.12617. [Epub ahead of print]

PMID:
30427098
5.

Relation of Ratio of Left Ventricular Ejection Fraction to Left Ventricular End-Diastolic Pressure to Long-Term Prognosis After ST-Segment Elevation Acute Myocardial Infarction.

Ndrepepa G, Cassese S, Emmer M, Mayer K, Kufner S, Xhepa E, Fusaro M, Laugwitz KL, Schunkert H, Kastrati A.

Am J Cardiol. 2018 Oct 23. pii: S0002-9149(18)31960-X. doi: 10.1016/j.amjcard.2018.10.007. [Epub ahead of print]

PMID:
30424868
6.

DNA Sequence Variation in ACVR1C Encoding the Activin-Receptor Like Kinase 7 Influences Body Fat Distribution and Protects Against Type 2 Diabetes.

Emdin CA, Khera AV, Aragam K, Haas M, Chaffin M, Klarin D, Natarajan P, Bick A, Zekavat SM, Nomura A, Ardissino D, Wilson JG, Schunkert H, McPherson R, Watkins H, Elosua R, Bown MJ, Samani NJ, Baber U, Erdmann J, Gupta N, Danesh J, Saleheen D, Gabriel S, Kathiresan S.

Diabetes. 2018 Nov 2. pii: db180857. doi: 10.2337/db18-0857. [Epub ahead of print]

PMID:
30389748
7.

Comparison of Vascular Closure Devices Versus Manual Compression After Femoral Artery Puncture in Women.

Gewalt SM, Helde SM, Ibrahim T, Mayer K, Schmidt R, Bott-Flügel L, Hoppe K, Ott I, Hieber J, Morath T, Byrne RA, Kufner S, Cassese S, Hoppmann P, Fusaro M, Schunkert H, Laugwitz KL, Kastrati A, Schüpke S; Instrumental Sealing of Arterial Puncture Site—CLOSURE Device Versus Manual Compression (ISAR-CLOSURE) Trial Investigators.

Circ Cardiovasc Interv. 2018 Aug;11(8):e006074. doi: 10.1161/CIRCINTERVENTIONS.117.006074.

PMID:
30354782
8.

Druggability of Coronary Artery Disease Risk Loci.

Tragante V, Hemerich D, Alshabeeb M, Brænne I, Lempiäinen H, Patel RS, den Ruijter HM, Barnes MR, Moore JH, Schunkert H, Erdmann J, Asselbergs FW.

Circ Genom Precis Med. 2018 Aug;11(8):e001977. doi: 10.1161/CIRCGEN.117.001977.

PMID:
30354342
9.

Genetic Susceptibility Loci for Cardiovascular Disease and Their Impact on Atherosclerotic Plaques.

van der Laan SW, Siemelink MA, Haitjema S, Foroughi Asl H, Perisic L, Mokry M, van Setten J, Malik R, Dichgans M, Worrall BB; METASTROKE Collaboration of the International Stroke Genetics Consortium, Samani NJ, Schunkert H, Erdmann J, Hedin U, Paulsson-Berne G, Björkegrenn JLM, de Borst GJ, Asselbergs FW, den Ruijter FW, de Bakker PIW, Pasterkamp G.

Circ Genom Precis Med. 2018 Sep;11(9):e002115. doi: 10.1161/CIRCGEN.118.002115.

PMID:
30354329
10.

Critical adverse events during transfemoral TAVR in conscious sedation. Is an anesthesiologic support mandatory?

Mayr NP, Wiesner G, Husser O, Joner M, Michel J, Knorr J, Pellegrini C, Bleiziffer S, Schunkert H, Lange R, Tassani-Prell P.

Cardiovasc Revasc Med. 2018 Sep;19(6S):41-46. doi: 10.1016/j.carrev.2018.06.014. Epub 2018 Jun 21.

PMID:
30327095
11.

Lp-PLA2, scavenger receptor class B type I gene (SCARB1) rs10846744 variant, and cardiovascular disease.

Manichaikul A, Wang XQ, Li L, Erdmann J, Lettre G, Bis JC, Waterworth D, Cushman M, Jenny NS, Post WS, Palmas W, Tsai MY, Wallentin L, White H, Schunkert H, O'Donnell CJ, Herrington DM, Rich SS, O'Donoghue ML, Rodriguez A.

PLoS One. 2018 Oct 5;13(10):e0204352. doi: 10.1371/journal.pone.0204352. eCollection 2018.

12.

Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry.

Schmidt N, Dressel A, Grammer TB, Gouni-Berthold I, Julius U, Kassner U, Klose G, König C, Koenig W, Otte B, Parhofer KG, Reinhard W, Schatz U, Schunkert H, Steinhagen-Thiessen E, Vogt A, Laufs U, März W.

Atherosclerosis. 2018 Oct;277:314-322. doi: 10.1016/j.atherosclerosis.2018.08.050.

13.

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC).

EAS Familial Hypercholesterolaemia Studies Collaboration; EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) Investigators.

Atherosclerosis. 2018 Oct;277:234-255. doi: 10.1016/j.atherosclerosis.2018.08.051.

PMID:
30270054
14.

[Management of arterial hypertension : ESC/ESH guidelines 2018].

Schunkert H.

Herz. 2018 Dec;43(8):695-700. doi: 10.1007/s00059-018-4758-3. German.

PMID:
30255307
15.

Ultrasound-guided thrombin injection for treatment of femoral artery pseudoaneurysm with concomitant AV-fistula - a retrospective single centre experience.

Steppich B, Schürmann F, Bruskina O, Hadamitzky M, Kastrati A, Schunkert H, Fusaro M, Ott I.

Vasa. 2018 Oct;47(6):507-512. doi: 10.1024/0301-1526/a000732. Epub 2018 Sep 3.

PMID:
30175945
16.

2018 ESC/ESH Guidelines for the management of arterial hypertension.

Williams B, Mancia G, Spiering W, Agabiti Rosei E, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I; ESC Scientific Document Group .

Eur Heart J. 2018 Sep 1;39(33):3021-3104. doi: 10.1093/eurheartj/ehy339. No abstract available.

PMID:
30165516
17.

Prophylactic ECMO during TAVI in patients with depressed left ventricular ejection fraction.

Trenkwalder T, Pellegrini C, Holzamer A, Rheude T, Riester J, Reinhard W, Mayr NP, Kasel AM, Gaede L, Blumenstein J, Kastrati A, Schunkert H, Joner M, Hilker M, Hengstenberg C, Husser O.

Clin Res Cardiol. 2018 Aug 28. doi: 10.1007/s00392-018-1364-6. [Epub ahead of print]

PMID:
30155732
18.

One-Year Outcomes after PCI Strategies in Cardiogenic Shock.

Thiele H, Akin I, Sandri M, de Waha-Thiele S, Meyer-Saraei R, Fuernau G, Eitel I, Nordbeck P, Geisler T, Landmesser U, Skurk C, Fach A, Jobs A, Lapp H, Piek JJ, Noc M, Goslar T, Felix SB, Maier LS, Stepinska J, Oldroyd K, Serpytis P, Montalescot G, Barthelemy O, Huber K, Windecker S, Hunziker L, Savonitto S, Torremante P, Vrints C, Schneider S, Zeymer U, Desch S; CULPRIT-SHOCK Investigators.

N Engl J Med. 2018 Nov 1;379(18):1699-1710. doi: 10.1056/NEJMoa1808788. Epub 2018 Aug 25.

PMID:
30145971
19.

Long-Term Prognosis of Patients With Takotsubo Syndrome.

Ghadri JR, Kato K, Cammann VL, Gili S, Jurisic S, Di Vece D, Candreva A, Ding KJ, Micek J, Szawan KA, Bacchi B, Bianchi R, Levinson RA, Wischnewsky M, Seifert B, Schlossbauer SA, Citro R, Bossone E, Münzel T, Knorr M, Heiner S, D'Ascenzo F, Franke J, Sarcon A, Napp LC, Jaguszewski M, Noutsias M, Katus HA, Burgdorf C, Schunkert H, Thiele H, Bauersachs J, Tschöpe C, Pieske BM, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Hasenfuß G, Karakas M, Koenig W, Rottbauer W, Said SM, Braun-Dullaeus RC, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Opolski G, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Crea F, Dichtl W, Empen K, Felix SB, Delmas C, Lairez O, El-Battrawy I, Akin I, Borggrefe M, Horowitz J, Kozel M, Tousek P, Widimský P, Gilyarova E, Shilova A, Gilyarov M, Winchester DE, Ukena C, Bax JJ, Prasad A, Böhm M, Lüscher TF, Ruschitzka F, Templin C.

J Am Coll Cardiol. 2018 Aug 21;72(8):874-882. doi: 10.1016/j.jacc.2018.06.016.

PMID:
30115226
20.

Sex and Long-Term Outcomes After Implantation of Absorb Bioresorbable Vascular Scaffold for Treatment of Coronary Artery Disease.

Baquet M, Hoppmann P, Grundmann D, Schmidt W, Kufner S, Theiss HD, Brunner S, Wiebe J, Eickhoff M, Jochheim D, Byrne RA, Laugwitz KL, Schunkert H, Massberg S, Kastrati A, Mehilli J.

EuroIntervention. 2018 Aug 14. pii: EIJ-D-18-00603. doi: 10.4244/EIJ-D-18-00603. [Epub ahead of print]

Supplemental Content

Loading ...
Support Center